Waldron Private Wealth’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.72M | Sell |
13,391
-12
| -0.1% | -$1.41K | 0.06% | 108 |
|
|
2026
Q1 | $1.61M | Sell |
13,403
-291
| -2% | -$33.6K | 0.06% | 106 |
|
|
2025
Q4 | $1.44M | Sell |
13,694
-1,013
| -7% | -$95.1K | 0.06% | 112 |
|
|
2025
Q3 | $1.25M | Sell |
14,707
-165
| -1% | -$13.6K | 0.05% | 124 |
|
|
2025
Q2 | $1.19M | Sell |
14,872
-739
| -5% | -$58.7K | 0.05% | 119 |
|
|
2025
Q1 | $1.41M | Sell |
15,611
-14,926
| -49% | -$1.39M | 0.07% | 107 |
|
|
2024
Q4 | $3.04M | Sell |
30,537
-720
| -2% | -$74.2K | 0.12% | 88 |
|
|
2024
Q3 | $3.55M | Sell |
31,257
-33
| -0.1% | -$3.92K | 0.15% | 78 |
|
|
2024
Q2 | $3.9M | Sell |
31,290
-88
| -0.3% | -$11.3K | 0.17% | 66 |
|
|
2024
Q1 | $4.16M | Buy |
31,378
+1,578
| +5% | +$195K | 0.19% | 64 |
|
|
2023
Q4 | $3.27M | Sell |
29,800
-8,676
| -23% | -$901K | 0.16% | 77 |
|
|
2023
Q3 | $3.99M | Sell |
38,476
-826
| -2% | -$89K | 0.21% | 63 |
|
|
2023
Q2 | $4.56M | Sell |
39,302
-893
| -2% | -$101K | 0.23% | 54 |
|
|
2023
Q1 | $4.31M | Buy |
40,195
+4,211
| +12% | +$455K | 0.21% | 64 |
|
|
2022
Q4 | $3.12M | Hold |
35,984
| – | – | 0.19% | 78 |
|
|
2022
Q3 | $3.12M | Buy |
35,984
+999
| +3% | +$89.2K | 0.19% | 78 |
|
|
2022
Q2 | $3.21M | Buy |
34,985
+1,065
| +3% | +$94.4K | 0.18% | 77 |
|
|
2022
Q1 | $2.81M | Buy |
33,920
+868
| +3% | +$68.4K | 0.14% | 95 |
|
|
2021
Q4 | $2.56M | Buy |
33,052
+1,971
| +6% | +$157K | 0.13% | 100 |
|
|
2021
Q3 | $2.35M | Buy |
31,081
+2,283
| +8% | +$174K | 0.14% | 97 |
|
|
2021
Q2 | $2.26M | Buy |
28,798
+1,206
| +4% | +$89.7K | 0.14% | 86 |
|
|
2021
Q1 | $2.05M | Buy |
27,592
+1,076
| +4% | +$79.4K | 0.14% | 85 |
|
|
2020
Q4 | $2.09M | Sell |
26,516
-791
| -3% | -$60.5K | 0.16% | 80 |
|
|
2020
Q3 | $2.18M | Buy |
27,307
+1,362
| +5% | +$107K | 0.19% | 74 |
|
|
2020
Q2 | $1.93M | Buy |
25,945
+365
| +1% | +$27.5K | 0.17% | 77 |
|
|
2020
Q1 | $1.89M | Buy |
25,580
+9,856
| +63% | +$775K | 0.2% | 73 |
|
|
2019
Q4 | $1.37M | Sell |
15,724
-122
| -0.8% | -$10K | 0.12% | 93 |
|
|
2019
Q3 | $1.28M | Buy |
15,846
+120
| +0.8% | +$9.62K | 0.13% | 92 |
|
|
2019
Q2 | $1.27M | Sell |
15,726
-755
| -5% | -$57.8K | 0.13% | 76 |
|
|
2019
Q1 | $1.32M | Buy |
16,481
+2,614
| +19% | +$196K | 0.15% | 74 |
|
|
2018
Q4 | $1.01M | Buy |
13,867
+4,503
| +48% | +$318K | 0.15% | 70 |
|
|
2018
Q3 | $633K | Buy |
9,364
+3,127
| +50% | +$199K | 0.12% | 84 |
|
|
2018
Q2 | $361K | Sell |
6,237
-2,374
| -28% | -$134K | 0.08% | 115 |
|
|
2018
Q1 | $447K | Buy |
8,611
+133
| +2% | +$7.18K | 0.1% | 87 |
|
|
2017
Q4 | $455K | Buy |
8,478
+157
| +2% | +$8.7K | 0.11% | 83 |
|
|
2017
Q3 | $508K | Buy |
8,321
+68
| +0.8% | +$4.12K | 0.14% | 72 |
|
|
2017
Q2 | $504K | Sell |
8,253
-9,823
| -54% | -$598K | 0.16% | 56 |
|
|
2017
Q1 | $1.09M | Buy |
18,076
+6,363
| +54% | +$386K | 0.27% | 47 |
|
|
2016
Q4 | $657K | Sell |
11,713
-230
| -2% | -$13.5K | 0.23% | 50 |
|
|
2016
Q3 | $711K | Buy |
11,943
+315
| +3% | +$18.4K | 0.26% | 43 |
|
|
2016
Q2 | $639K | Buy |
11,628
+356
| +3% | +$18.9K | 0.23% | 49 |
|
|
2016
Q1 | $569K | Buy |
11,272
+2,068
| +22% | +$101K | 0.21% | 58 |
|
|
2015
Q4 | $463K | Sell |
9,204
-1,666
| -15% | -$84K | 0.17% | 70 |
|
|
2015
Q3 | $512K | Buy |
+10,870
| New | +$577K | 0.22% | 46 |
|
Other funds holding MRK
ECSS
Waldron Private Wealth's MRK Position: Q2 2026 in Review
Waldron Private Wealth reduced its Merck (MRK) stake by 0.09% in Q2 2026, selling an estimated $1.41K and leaving 13,391 shares worth $1.72M. The position accounts for 0.06% of the portfolio, ranked #108.
Waldron Private Wealth first reported a position in MRK in Q3 2015 and has held it in 44 quarters since. The position peaked at $4.56M in Q2 2023. 1,855 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Waldron Private Wealth held 13,391 shares of Merck worth $1.72M as of Q2 2026.
- Waldron Private Wealth sold 12 Merck shares in Q2 2026, an estimated $1.41K.
- Merck made up 0.06% of Waldron Private Wealth's portfolio in Q2 2026, its #108 holding.
- Waldron Private Wealth first reported a position in Merck in Q3 2015 and has held it in 44 quarters since.
- Waldron Private Wealth's Merck position peaked at $4.56M in Q2 2023.
- 1,855 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Waldron Private Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.